1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    Three scientists wearing white coats and blue gloves dance together in a lab.
    Healthcare Shares

    Can the CSL share price crack $300 before the year's out?

    | Sebastian Bowen

    Can CSL shares head back to $300 this year?

    Read more »

    A man wearing a white coat holds his hands up and mouth open with joy.
    Investing Strategies

    3 ASX shares to buy in a sector ready to explode: expert

    | Tony Yoo

    The market is 50% higher since the pandemic crash, but one industry has merely travelled sideways. Now it's ready to…

    Read more »

    ASX 300 share investors in suits running a race on an athletics track
    Healthcare Shares

    Why is the CSL share price smashing the ASX 200 on Thursday?

    | Bronwyn Allen

    It's been a good day so far for the biotherapeutics giant. But is it a buy?

    Read more »

    A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
    Healthcare Shares

    Are CSL shares a good buy right now?

    | Tristan Harrison

    Is this ASX share giant a healthy opportunity for investors? Brokers have their say…

    Read more »

    two chemists celebrate by jokingly clinking two containers of chemicals while they wear white laboratory coats and protective glasses in their lab.
    Investing Strategies

    2 big name ASX companies ready for a 'share price recovery': experts

    | Tony Yoo

    If you are seeking shelter in reliable brands amid chaotic times, here is a pair of stocks that professional investors…

    Read more »

    ASX shares Business man marking buy on board and underlining it
    Broker Notes

    Leading brokers name 3 ASX shares to buy today

    | James Mickleboro

    Here's why brokers rate these ASX shares as buys...

    Read more »

    medical asx share price represented by doctor giving thumbs up
    Healthcare Shares

    Own CSL shares? Here's what brokers are saying about its R&D pipeline

    | James Mickleboro

    What are analysts saying about CSL's R&D pipeline?

    Read more »

    Four investors stand in a line holding cash fanned in their hands with thoughtful looks on their faces.
    Blue Chip Shares

    Why I'm seriously considering investing $10,000 in these ASX 200 shares

    | James Mickleboro

    Here are two ASX 200 shares I could invest in very soon...

    Read more »

    Smiling man with phone in wheelchair watching stocks and trends on computer
    Share Market News

    5 things to watch on the ASX 200 on Friday

    | James Mickleboro

    On Thursday, the S&P/ASX 200 Index (ASX: XJO) tumbled deep into the red after the US Federal Reserve increased rates by…

    Read more »

    A CSL scientist looking through a telescope in a lab
    Healthcare Shares

    What's happening with the CSL share price today?

    | Monica O'Shea

    The ASX healthcare company has given an investor presentation today ... but what did it say?

    Read more »

    A man smiles as he holds bank notes in front of a laptop.
    Blue Chip Shares

    Here's why brokers rate these blue chip ASX 200 shares as buys

    | James Mickleboro

    These blue chip have been rated as buys...

    Read more »

    Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
    Broker Notes

    Top brokers name 3 ASX shares to buy today

    | James Mickleboro

    Brokers are feeling bullish about these ASX shares...

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note